Page last updated: 2024-10-24

candesartan and Lupus Erythematosus, Systemic

candesartan has been researched along with Lupus Erythematosus, Systemic in 4 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research Excerpts

ExcerptRelevanceReference
" In addition to treatment with prednisolone, they were administered anticoagulants(warfarin, or aspirin, or heparin) for APSN and an angiotensin II receptor blocker, candesartan, for the hypertension."3.71[Two cases of systemic lupus erythematosus accompanied by antiphospholipid syndrome nephropathy without immune complex nephritis]. ( Kawakami, K; Komiya, T; Negoro, N; Okada, S; Okamura, M; Okazaki, M; Sumi, T; Tsukamoto, J; Yoshikawa, J, 2002)
"Edema is a common symptom in elderly patients and we frequently observe drug-induced edema."1.31[A case of severe systemic edema in an elderly hypertensive patient with systemic lupus erythematodes during long-term treatment with anti-hypertensive drugs]. ( Higaki, J; Iegushi, K; Maekawa, Y; Moriguchi, A; Ogihara, T; Ohishi, M; Orita, H; Rakugi, H; Sugimoto, K, 2001)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katayama, A1
Otsuka, F1
Tanabe, K1
Tsukamoto, N1
Yamanaka, R1
Matsumoto, Y1
Nasu, Y1
Makino, H1
Goykhman, P1
Mehta, PK1
Minissian, M1
Thomson, LE1
Berman, DS1
Ishimori, ML1
Wallace, DJ1
Weisman, MH1
Shufelt, CL1
Bairey Merz, CN1
Komiya, T1
Okamura, M1
Kawakami, K1
Okazaki, M1
Tsukamoto, J1
Okada, S1
Sumi, T1
Negoro, N1
Yoshikawa, J1
Maekawa, Y1
Sugimoto, K1
Ohishi, M1
Moriguchi, A1
Rakugi, H1
Iegushi, K1
Orita, H1
Higaki, J1
Ogihara, T1

Other Studies

4 other studies available for candesartan and Lupus Erythematosus, Systemic

ArticleYear
Unexpected occurrence of adrenal Cushing's syndrome in a patient with systemic lupus erythematosus.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:5

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Angiomyolipoma; Antihyperten

2011
Subendocardial ischemia and myocarditis in systemic lupus erythematosus detected by cardiac magnetic resonance imaging.
    The Journal of rheumatology, 2012, Volume: 39, Issue:2

    Topics: Anti-Inflammatory Agents; Benzimidazoles; Biphenyl Compounds; Chest Pain; Coronary Angiography; Coro

2012
[Two cases of systemic lupus erythematosus accompanied by antiphospholipid syndrome nephropathy without immune complex nephritis].
    Nihon Jinzo Gakkai shi, 2002, Volume: 44, Issue:8

    Topics: Adult; Angiotensin Receptor Antagonists; Anticoagulants; Antigen-Antibody Complex; Antihypertensive

2002
[A case of severe systemic edema in an elderly hypertensive patient with systemic lupus erythematodes during long-term treatment with anti-hypertensive drugs].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2001, Volume: 38, Issue:5

    Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Bipheny

2001